BEUDAMED
    328 results · 58ms · Sources: EU EUDAMED, US FDA
    Filters FDA Pre Market Approval ×

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·Absorb GTi Bioresorbable Vascular Scaffold (BVS) System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA™ Implant System

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Implant, Dermal, For Aesthetic Use In The Hands

    FDA Pre-Market Approval
    FDA Class 3 ·Restylane Lyft with Lidocaine

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA™ System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System.

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System

    Absorbable Coronary Drug-Eluting Stent

    FDA Pre-Market Approval
    FDA Class 3 ·ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD (BVS) SYSTEM

    Implant, Dermal, For Aesthetic Use In The Hands

    FDA Pre-Market Approval
    FDA Class 3 ·RADIESSE INJECTABLE IMPLANT

    Stimulator, Bone Growth, Non-Invasive

    FDA Pre-Market Approval
    FDA Class 3 ·EBI BONE HEALING SYSTEM(R)-MODEL 123